Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Carbiotix launches simplified & lower price gut health test

Carbiotix (publ) ("Carbiotix") announces today that the company has launched a new competitive gut health test within its OneGut second generation diagnostic platform. The new “Basic” test, which will be sold at a lower price, follows the launch of the company’s “Standard” test in February of 2020 and now provides an even more cost effective option for the long-term monitoring of gut health. The launch of the Basic test reinforces Carbiotix market position as a leading provider of white label consumer gut health tests for food & beverage, supplement and pharmaceutical companies, as well as

Ulf Henning to resign as CFO of myFC

Ulf Henning has decided to step down from his position as CFO of myFC due to retirement. The process to recruit his successor has been initiated.Ulf Henning has been the CFO of myFC since 2012. He will remain in his position until the new CFO is in place, ensuring an orderly transition. “I would like to thank Ulf for his services to myFC over the past 8 years and wish him well in his retirement,” says Michael Glantz, CEO of myFC. This information is information that myFC is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication,

Klaria Pharma Holding AB Partners with Chilam Enterprise Ltd To Power Expansion to Medical Cannabis Sector

Stockholm and London, August 6[th], 2020 I Klaria Pharma Holding AB and its subsidiary company Cannabis Delivery Sciences (CDS) today announced that Chilam Enterprise Ltd  has entered into a non-exclusive license agreement with CDS for the right to sell CDS’ Cannabis Alginate Films in Europe.  Starting in 2021, Chilam will supply the European medical sector with GMP-compliant medical cannabis formulated in the Alginate Film.Chilam specialises in cannabis research, cultivation, production and distribution.  Focused on developing

Teleste's half year financial report 2020 will be published on August 13th - Invitation to press briefing

TELESTE CORPORATION      INVESTOR NEWS     6.8.2020   AT 9:30 EET TELESTE'S HALF YEAR FINANCIAL REPORT 2020 WILL BE PUBLISHED ON AUGUST 13th - INVITATION TO PRESS BRIEFING Teleste will publish its half year financial report 1 January – 30 June 2020 as a stock exchange release on August 13[th] approx. at 08:30 a.m. EET. A briefing for investors, media and analysts and will be held the same day in Helsinki hosted by CEO, Mr.  Jukka Rinnevaara. Teleste’s CFO, Mr. Juha Hyytiäinen will also be present in the briefing. PRESS BRIEFING (held in Finnish):Date: Thursday, August 13[th] 2020

Notice of Annual General Meeting in Sectra AB (publ)

Linköping, Sweden – August 6, 2020 – The shareholders of the medical imaging IT and cyber security company Sectra AB (publ) are hereby invited to the Annual General Meeting held on Tuesday, September 8, 2020 at 3.30 p.m. (CET) at Collegium, Teknikringen 7, Linköping, Sweden.Extraordinary measures due to the COVID-19 pandemic Sectra seeks to safeguard the wellbeing of its shareholders and endeavours to help limit the spread of coronavirus in the best possible way. The Board of Directors of Sectra has therefore decided to implement certain precautionary measures in connection with the

Nanoform convenes EGM to elect Cynthia Schwalm as board member

COMPANY RELEASE August 6, 2020 9:10 am Helsinki time Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, will convene an extraordinary general meeting (EGM) on September 1, 2020 at 10 am Helsinki time to elect Cynthia Schwalm as a new board member. The notice to the EGM was published simultaneously with this release.Cynthia, a renowned Biotechnology CEO and pharmaceutical leader, began her career as an Oncology and Critical Care Nurse at the Albert Einstein Medical Center & Rutgers University Camden Medical Center, where she

Notice to the extraordinary General Meeting of NANOFORM FINLAND PLC

The shareholders of Nanoform Finland Plc (business ID: 2730572-8) are hereby invited to the Extraordinary General Meeting to be held on 1 September 2020 (EET) at 10:00am at Viikinkaari 4, Helsinki, Finland (Cultivator II, meeting room 105, 1[st] floor). A. Agenda of the General Meeting The following matters will be considered at the Extraordinary General Meeting: 1. Opening of the meeting 2. Calling the meeting to order 3. Election of persons to scrutinize the minutes and to supervise the counting of votes 4. Recording the legality of the meeting 5. Recording the

Etrion Releases Second Quarter 2020 Results

August 6, 2020, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), an  independent renewable power producer, released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three and six months ended June 30, 2020.  Etrion delivered steady project-level results in the second quarter of 2020 from its Japanese assets. The optimization of the Japanese corporate structure and renegotiation of the operations and maintenance (“O&M”) contracts partially offset the impact of lower

Gunnebo takes next step on the transformation journey – the Swedish Gateway operation divested

As part of Gunnebo’s transformation journey towards a more focused, profitable and innovation-oriented company the Swedish Gateway operation has been divested.The divestment is in line with Gunnebo’s strategy to create more focus on Business Units: Entrance Control, Safe Storage and Cash Management. It is also the result of the ongoing evaluation being carried out to estimate the future potential of each operation within the Business Unit Other Business. Gateway contributed negatively to the Full Year EBITA result 2019 with MSEK –22 and in January-June 2020 with MSEK –7. A non-cash flow

Aker Solutions ASA: Company Presentations Related to Offshore Wind and Carbon Capture Spin-Offs

August 6, 2020 - Reference is made to the release on July 17, 2020, where Aker Solutions announced its intention to spin off the company’s offshore wind development and carbon capture businesses into two separate companies.The two companies, Aker Offshore Wind Holding AS and Aker Carbon Capture AS, are intended to be listed on Merkur Market operated by the Oslo Stock Exchange, following private placement processes to secure funding for future operations.  Carnegie AS and Skandinaviska Enskilda Banken AB (publ) have been appointed as financial advisors for the process. In preparation

Metso Outotec to supply primary crushing stations for a mining company in Russia

Metso Outotec Corporation’s press release on August 6, 2020, at 09:00 a.m. EESTMetso Outotec will deliver two primary crushing stations for a mine located in the Russian Far East. The EUR 23 million order, which has been booked in former Metso Minerals’ Q2 2020 orders received, will be delivered by Metso Outotec Corporation (formed when Metso Corporation and Outotec Oyj completed the combination of Metso’s Minerals business and Outotec on June 30, 2020). The commissioning of the equipment is expected to take place in 2023. The delivery includes two primary crushing stations with Metso

MPC Container Ships ASA announces commencement of subscription period for the subsequent offering

NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE. Oslo, 6 August 2020 – Reference is made to the stock exchange announcements by MPC Container Ships ASA ("MPC" or the "Company") on 10 and 13 July 2020, respectively, regarding the completion of a private placement of 260,000,000 new shares (the "

Terveystalo Group half-year report 1 January – 30 June 2020

COVID-19 IMPACTED THE BUSINESS HEAVILY IN Q2 - NORMALIZATION OF VOLUMES HAS BEGUN Terveystalo Plc, half-year report, 6 August 2020 at 9:00 EEST This release is a summary of Terveystalo's half-year report 1 January – 30 June 2020. The full release is attached to this stock exchange release and is available on our website at: https://www.terveystalo.com/en/investors/Financial-information/. April–June 2020 in brief · Revenue decreased by 19.1 percent year-on-year to EUR 209.2 million (258.6). · Adjusted[1) ]earnings before interest, taxes, and amortization (EBITA) decreased by

Revenio Group Corporation: Half-year financial report, January 1 - June 30, 2020

Revenio Group Corporation, Stock Exchange Release, August 6, 2020 at 9.00Revenio Group Corporation: Half-year Financial Report H1/2020 Figures in brackets refer to the same period in the previous year, unless otherwise stated. Strong quarter despite the Covid-19 pandemic. April–June 2020 · Net sales totaled EUR 13.7 (11.8) million, showing reported increase of 15.6% · Operating profit was EUR 3.4 (0.9) million · Operating profit for the reference period was weighed down by non-recurring acquisition costs amounting to EUR 1.82 million. Operating profit adjusted by non-

Nel ASA: Employee Share Option Program

(Oslo, 6 August 2020) Nel ASA (the Company) today has resolved to grant options to additional employees of the Company that fulfill the requirements for participation in the employee share option plan. The grant of options is based on the authorization from Nel's annual general meeting of 13 May 2020 to issue new shares in connection with Nel's incentive plan for employees, and the same annual general meeting's adoption of the statement of the board regarding long term incentive plans. A total of 262,000 share options were granted on terms and conditions equivalent to the options issued

CapMan Growth establishes a new growth fund and invests in sound processing technology leader Neural DSP

The new fund is looking to invest in fast growing companies and has attracted some of the most successful Finnish entrepreneurs to back it. CapMan Growth has established a new €85 million growth fund which makes significant minority investments in growth stage companies with ambitious growth and expansion goals. The fund has raised €74 million in the first round and has a target size of €85 million. “There is a lot of potential in Finland in this investment class. We have many high growth companies and skillful entrepreneurs who have excellent chances for international success”, says

CapMan Plc’s financial reporting in 2021

CapMan Plc Stock Exchange Release / Financial Calendar6 August 2020 at 8.32 a.m. EEST CapMan Plc’s financial reporting in 2021 CapMan Group will publish its Financial Statements Bulletin for 2020 on Thursday, 4 February 2021. The 2020 Annual Report, including the Financial Statements and the Report of the Board of Directors, will be published in February 2021 during week 8. The Annual General Meeting of Shareholders will be held on Wednesday, 17 March 2021 at 10.00 a.m. EET in Helsinki. A shareholder must declare his or her demands in writing to CapMan Plc’s Board of Directors by

SpareBank 1 SR-Bank ASA (SRBANK): A result marked by good operations but high impairments

SpareBank 1 SR-Bank achieved a pre-tax profit of NOK 513 million in the first half of 2020, compared with NOK 2,432 million in the same period last year. The result is marked by good operations and a good influx of customer, but weakened by increased impairments. The return on equity after tax was 3.7%, compared with 18.8% for the same period in 2019. Impairments on loans and guarantees totalled NOK 1,391 million, compared with NOK 30 million in the same period last year. The increased impairments are the result of continued challenging market conditions for offshore related companies.

CapMan Plc 1–6 2020 Half-Year Report

CapMan Plc Stock Exchange Release / H1 2020 Half-Year Report6 August 2020 at 8:30 a.m. EEST CapMan Plc 1–6 2020 Half-Year Report Results and significant events in January–June 2020: · Group turnover was MEUR 20.7 1 Jan–30 Jun 2020 (MEUR 22.6 · 1 Jan–30 Jun 2019), a decrease of 9 per cent from the comparison period. · Management Company business turnover was MEUR 13.7 (MEUR 12.8), growth was 7 per cent from the comparison period, and operating profit MEUR 3.5 (MEUR 1.7). · Service business turnover was MEUR 7.0 (MEUR 9.8), decrease was 29 per cent from the comparison

Kongsberg Automotive reports Q2 2020 results

KEY TOPICS ·Revenues declined strongly by MEUR 140 (-48 %) YoY to MEUR 154, includingnegative currency translation effects of MEUR 3.9. The downturn in Q2 2020 iswholly driven by Corona virus pandemic related shortfalls in sales volume inEuropean and North American KA plants: ·Revenues in Europe and in the Americas declined by around 56% YoY and 57%respectively. ·Revenues in China increased by around 25% YoY, attributable to the quickrecovery from the Corona virus pandemic effects and KA market share gains inthat market. ·Revenues in all KA

Nolato acquires US-based medtech manufacturer with annual sales of approximately SEK 1.8 billion

Nolato has signed an agreement to acquire US-based GW Plastics. The company, which was founded in 1955, has annual sales of approximately SEK 1.8 billion and an EBITA margin of around 7%. The acquisition price, including contingent consideration, is estimated at approximately SEK 2 billion. The acquisition provides significant volumes and a strong position in North America for the Medical Solutions business area, offering additional opportunities for growth and underpinning existing core customer relationships. The acquisition means Nolato has a solid global position on the three key

Independent Review Committee Recommends Nordic Nanovector to focus on one dosage arm for the Pivotal PARADIGME Phase 2b Trial in Patients with 3L R/R FL

Oslo, Norway, 6 August 2020 Nordic Nanovector ASA (OSE: NANO) today announces that, following a planned interim analysis of the PARADIGME Phase 2b pivotal trial of Betalutin® in patients with relapsed/refractory follicular lymphoma (FL), the Independent Review Committee (IRC) has recommended Nordic Nanovector to focus on one dosage arm (15 MBq/kg Betalutin® after a pre-dose of 40 mg lilotomab; “40/15”) to completion. In this very difficult to treat patient population (bulky disease, patients refractory to standard therapies) the interim analysis confirmed activity. Betalutin®, as a

SHAMARAN ANNOUNCES ISSUANCE OF COMMON SHARES

Vancouver, BC, August 6, 2020 /CNW/ - ShaMaran Petroleum Corp. ("ShaMaran" or the "Company") (SNM - TSXV, Nasdaq First North Growth Market) provides this announcement following the full drawdown of the Liquidity Guarantee issued by Nemesia S.á.r.l., a company controlled by a trust settled by the late Adolf H. Lundin, (“Nemesia”) and the deposit of US$ 22.8 million (the “Principal Amount”) into the debt service retention account of the Company for use in paying obligations relating to the Company’s 12% senior unsecured bonds due 2023 (ISIN: NO 001082645.6) as previously reported in the

Caverion Corporation’s Half-year Financial Report for 1 January – 30 June 2020

Caverion Corporation Half-year Financial Report 6 August 2020 at 8.00 a.m. EESTCaverion Corporation’s Half-year Financial Report for 1 January – 30 June 2020 Corona crisis impacted revenue and EBITA, still improvement year-on-year, strong cash flow 1 April – 30 June 2020 · Revenue: EUR 518.5 (512.3) million, up by 1.2 percent, 3.3 percent in local currencies. Organic growth was -4.8 percent. Services business revenue up by 3.1 percent, 5.8 percent in local currencies. · Adjusted EBITDA: EUR 18.5 (10.0) million, or 3.6 (2.0) percent of revenue. · Adjusted EBITA: EUR 4.8 (-3.

There are no items matching the current filter
There are no more items matching the current filter
Back to top